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are established risk factors for DN [7, 8] . At the cellular level, an enhanced Na + /Li + countertransport in erythrocytes constitutes a genetic marker for DN [9--11] . This ion transport apparently represents a special mode of operation of the ubiquitously expressed Na + /H + exchanger [12] . Moreover, an increased activity of the Na + /H + exchanger has been observed in erythrocytes and cultured skin fibroblasts from IDDM patients with DN [13, 14] . Subsequent investigations have revealed, that the "enhanced Na + /H + exchanger phenotype"" is conserved in Epstein-Barr virus-immortalised lymphoblasts from patients with essential hypertension [15] as well as from IDDM patients with DN [16] . In hypertension, this enhanced Na + /H + exchanger activity appears to be ultimately caused by an increased activation of pertussis toxin (PTX)-sensitive G proteins which results in an enhanced cellular reactivity, e. g. increased agonist-stimulated rises in [Ca 2 + ] i and increased inositol 1,4,5-trisphosphate formation, as well as an accelerated cell growth [17, 18] . Because increased proliferation has already been shown in immortalised lymphoblasts [19] and skin fibroblasts [14] from IDDM patients with DN, we speculated that enhanced G protein activation could be a common denominator of enhanced cellular reactivity in both hypertension and DN. We have, therefore, established immortalised B lymphoblast cell lines from IDDM patients with (DN) and without diabetic nephropathy (DC). The results suggest, that patients with DN actually display an enhanced activation of PTX-sensitive G proteins. This finding may help to establish a novel hypothesis regarding the pathogenesis of DN.
Subjects, materials and methods
Materials. RPMI 1640 cell culture medium, L-glutamine and penicillin/streptomycin solution were from Gibco-BRL (Eggenstein, Germany). Fetal calf serum (FCS) was from Vitromex (Vilshofen, Germany). Platelet-activating factor (PAF) and mastoparan-7 (MAS-7) were obtained from Calbiochem (Bad Soden, Germany). Fura 2-AM was purchased from Molecular Probes (Eugene, Ore., USA). Guanine nucleotides were from Boehringer Mannheim (Mannheim, Germany).
]GTPgS, 1200--1400 Ci/mmol) was purchased from New England Nuclear-DuPont (Dreieich, Germany). Pertussis toxin was from List Biological Laboratories (Campbell, Calif., USA). The antiGa i,common antibody was obtained from Calbiochem and the peroxidase-conjugated goat-anti-rabbit antibody from Sigma (Deisenhofen, Germany).
Patient characteristics. The study groups consisted of 10 patients with IDDM without nephropathy (DC) and 15 IDDM patients with nephropathy (DN), duration of IDDM being at least 10 years. The nephropathy status of the patients was determined by a timed collection of urine (collection period either 2 × 2 h, or 24 h) and measurement of the albumin concentration by immunonephelometry. Nephropathy was defined as a persistent urinary albumin excretion of more than 20 mg/min or 30 mg/24 h. The urinary albumin excretion rate was measured at least two times for each patient. Estimates of the endogenous creatinine clearance were performed either as a 2 × 2 h or a 24 h creatinine clearance. All subjects had repeated measurements of blood pressure after 10 min of rest and antihypertensive medication was recorded. A family history of diabetes, hypertension, myocardial infarction, other cardiovascular diseases, stroke and hyperlipoproteinaemia was taken.
Characteristics of the two study groups are summarised in Table 1 . IDDM patients with and without DN did not differ significantly regarding age, duration of diabetes, gender, glycaemic control and body mass index. However, both groups differed with respect to the markers of renal disease. DN patients included six with microalbuminuria, seven with macroalbuminuria and two already on haemodialysis. Renal disease was also reflected by higher serum creatinine values in the DN group. In addition, hypertension was diagnosed more often in the DN group as reflected by antihypertensive treatment. Of 15 DN patients 8 were on antihypertensive medication, wherereas none of the 10 DC patients was treated with antihypertensives. Mean systolic and diastolic blood pressures were similar in both groups, although the diastolic blood pressure values in some of the patients in the DN group exceeded normotensive values. Additionally, in the DN group a family history of cardiovascular disease was reported more often (data not presented).
Lymphoblast culture. Fifty ml of blood was obtained from each patient, lymphocytes were isolated on a Ficoll-Diatrizoate Means ± SD, ranges are given in parentheses; a exclusive of two patients on haemodialysis; b p < 0.01 vs patients without nephropathy gradient (Ficoll Paque; Pharmacia, Freiburg, Germany) and immortalised as described [15] . Cells were routinely maintained in RPMI 1640 medium supplemented with 2 mmol/l l-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, and 10 % FCS. Measurements of intracellular signal transduction were not started before the 12th--16th week after immortalisation. Repeated measurements were performed for agoniststimulated increases in [Ca 2 + ] i and GTPgS binding with a minimum interval of 6 weeks between measurements to avoid fortuitous influences of the cell culture conditions.
Ca
2 + -measurements. Measurements of intracellular free calcium concentration ([Ca 2 + ] i ) were performed on cells seeded at 1 × 10 5 cells/ml and cultured for 24 h in serum-free RPMI 1640 medium. Cells resuspended at 2 × 10 6 cells/ml in serumfree medium were incubated with 3 mmol/l fura 2-AM for 30 min at 37°C. Thereafter, the cells were centrifuged and resuspended for an additional 30 min in RPMI 1640 medium containing 1 mmol/l Ca 2 + to allow for complete hydrolysis of the fluorescent dye. Before each single measurement, aliquots of cells (0.5--1 × 10 6 cells) were transferred to Eppendorf tubes, briefly centrifuged and resuspended in 2 ml pre-warmed HEPES buffer containing (in mmol/l): 135 NaCl, 5 KCl, 1 MgCl, 1 CaCl 2 , 10 Glucose, and 20 HEPES, pH 7.4. Measurements were performed using an LS 5B spectrofluorometer (Perkin Elmer Corp., Norwalk, Conn., USA) equipped with a thermostated cuvette holder and a fast-filter application. Cells were excited alternately at 340/380 nm, and emission was recorded every 0.1 s at 495 nm. For experiments under Ca 2 + -free conditions, 5 mmol/l EGTA (final concentration) was added to the cell suspension 30 s before addition of agonist. [Ca 2 + ] i was calculated as described [20] . On the day of the experiment, cells from each individual cell line were measured 3 to 7 times for each condition, and these measurements were repeated two to three times for each cell line several weeks or even months apart. 35 S]GTPgS binding to permeabilised cells was performed as described [21] . Lymphoblasts were growth-arrested as described above. After centrifugation (120 × g), the cell pellet was resuspended at 1 × 10 7 cells/ ml in a buffer containing (in mmol/l) 150 NaCl, 5 MgCl 2 , 1 EDTA, and 50 triethanolamine-HCL, pH 7.4. Aliquots (1 × 10 6 cells) were transferred to the reaction mixture consisting of the same buffer supplemented with 10 mmol/l digitonin, 100 mmol/l adenosine 5 ′-[b, g-imino] triphosphate and 10 mmol/l guanosine diphosphate (GDP), and the cells were permeabilised for 15 min at 30°C. Thereafter, 30 mmol/l mastoparan-7 (MAS-7) was added. After 1 min, the [ The reaction was stopped after 10 min by rapid filtration through nitrocellulose filters rinsed four times with 3 ml of ice-cold washing buffer consisting of 5 mmol/l MgCl 2 and 50 mmol/l Tris-HCL (pH 7.5) for separation of protein-bound and free radioactivity. The filters were counted in a liquid scintillation spectrometer. Non-specific binding was defined as that not competed for by 10 mmol/l unlabelled GTPgS. Experiments were performed on cell lines from five DC and nine DN patients because the method was too difficult to be performed on all cell lines simultaneously. This would have been necessary to obviate interassay variations.
Immunoblotting. Crude lymphoblast cell membranes were prepared by nitrogen cavitation as described [17] . Cells seeded at a density of 1 × 10 6 cells/ml in serum-containing RPMI 1640 medium and grown for 1 day were harvested, washed twice in phosphate-buffered saline (PBS), resuspended in icecold lysis buffer (in mmol/l: 250 sucrose, 1.5 MgCl 2 , 1 ATP, 3 benzamidine, 1 phenylmethylsulfonyl fluoride, 2 mg/ml soybean trypsin inhibitor, and 20 Tris/HCl, pH 7.5), and homogenised by nitrogen cavitation (15 min at 50 bar). The cavitate was centrifuged at 2500 × g for 10 min, and a crude membrane fraction was obtained from the resulting supernatant by centrifugation at 100 000 × g for 20 min. The resulting pellet was washed in a buffer consisting of (in mmol/l) 1 EDTA, 1 dithiothreitol, 3 benzamidine, 1 phenylmethylsulfonyl fluoride, 2 mg/ ml soybean trypsin inhibitor, and 20 Tris/HCl, pH 7.5, resuspended, and finally stored in the same buffer at --70°C.
Protein concentration was determined according to Bradford [22] with bovine IgG as standard. Membrane proteins (25 mg) were heated for 5 min at 95°C in sample buffer containing 5 % 2-mercaptoethanol. They were fractionated by SDS-PAGE electrophoresis according to Laemmli [23] Statistical analysis. All data are given as mean ± SD if not indicated otherwise. Comparison between groups were made using Student©s t-test or, if appropriate Mann-Whitney U test. Differences were regarded as significant at p less than 0.05. All calculations were performed using the computer program StatView, version 4.0 for Macintosh, Abacus Concepts, Inc. (Berkeley, Calif., USA). were not significantly different in lymphoblasts from both groups (DC: 84 ± 27 nmol/l, n = 83 measurements; DN: 87 ± 27 nmol/l, n = 165 measurements). Addition of 0.1 mmol/l PAF consistently induced a rapid, transient increase in [Ca 2 + ] i , which peaked within 15 to 30 s and then declined to a new steady state level above baseline (Fig. 1A, B) . We observed differences in the increase in [Ca 2 + ] i above basal levels between lymphoblasts from DN, and lymphoblasts from DC patients, which also resulted in different sizes of the areas under the curve (Fig. 1A, B) . Figure 2A , whereas in the DN group the mean increase above baseline amounted to 150.7 ± 61.5 nmol/l (n = 15). This difference was statistically significant (p = 0.005). A difference in the slope of the rise or decline in Ca 2 + mobilisation between the two groups was not noted (Fig. 1A, B) .
Results

PAF-stimulated increases in [Ca
Upon chelation of extracellular (Fig. 1C, D) , which ranged from 0--100 nmol/l in DC cell lines and from 30--140 nmol/l in DN cell lines (Fig. 2B) . The mean increase in [Ca (Fig. 2) , linear regression analysis revealed a significant correlation between the direct activation of G i type G proteins by MAS-7 and the PAF-induced increases in [Ca 2 + ] i (r 2 = 0.42; p = 0.012).
Ga i protein expression. To investigate whether enhanced G protein activation in B lymphoblasts from DN is caused by an overexpression of PTX-sensitive G proteins, the expression of Ga i was quantified by Western blot analysis. 
Discussion
We have established immortalised B lymphoblast cell lines from IDDM patients with and without DN. This experimental approach allows determination of potentially inherited abnormalities of intracellular signal transduction because confounding influences of the hyperglycaemic diabetic in vivo mileu are very unlikely to persist after prolonged cell culture. Subsequently, we quantified the PAF-induced increase in [Ca 2 + ] i , which is predominantly mediated via PTXsensitive G i -type G proteins in B lymphoblasts [17, 25] . Lymphoblasts from IDDM patients with DN displayed significantly higher increases in [Ca 2 + ] i above baseline compared to lymphoblasts from IDDM patients without DN both in the presence and absence of extracellular Ca 2 + ions. On the other hand, we found no correlation between the duration of IDDM or donor age and the increase in [Ca 2 + ] i (data not shown and [26] ). Agonist-evoked increases in [Ca 2 + ] i correlate reasonably well with the activation of G i proteins as inferred from MAS-7 stimulated binding of [ 35 S]GTPgS to permeabilised lymphoblasts. The fact that differences in stimulated GTPgS binding between DN and DC cell lines did not reach statistical significance is mainly due to the restricted number of respective determinations that could be performed under comparable experimental conditions. The enhanced activation of G i -type G proteins in DN is not caused by an overexpression which resembles our previous observation in cell lines from hypertensive subjects [17, 18] . Hence, the molecular reason for this remains to be unravelled.
It should be emphasised that the present study was not intended to be an epidemiological one. Immortalisation and prolonged culture of cell lines from large numbers of IDDM patients is desirable but hardly feasible. A striking similarity exists between the findings reported here and those published previously on immortalised lymphoblasts from IDDM patients with DN and patients with essential hypertension (without IDDM), which in our view, makes the present observations highly plausible: Thus, the phenotype of enhanced Na + /H + exchanger activity persists in immortalised B lymphoblasts [16, 19] and skin fibroblasts [13, 14] from DN patients and patients with hypertension [15] and is tightly linked to an accelerated cell proliferation. Both B lymphoblasts as well as skin fibroblasts from hypertensive patients with enhanced Na + /H + exchanger activity display a selective enhancement of activation of G i -type G proteins [17, 18] . It is, therefore, not too surprising that the same phenomenon, i. e. increased G i protein activation, is now also described in IDDM patients with DN. Furthermore, the findings presented here are supported by in vivo studies: IDDM patients with DN respond with an increased vasoconstriction to infusion of clonidine, which activates a 2 -adrenoceptors coupled to G i proteins, whereas vasoconstriction in response to the a 1 -adrenoceptor agonist phenylephrine, which activates PTX-insensitive G proteins, is not significantly different in IDDM patients with and without DN [27] . However, the striking similarities in terms of increased cellular signalling in both hypertension and DN may also cause some concern regarding a potential selection bias in this study and those performed by others [16, 19] . This concern relates to the relative excess of patients with hypertension in the DN group compared to the low number of hypertensive individuals in the DC group both in the present as well as in previous studies [16, 19] . It is, therefore, at present difficult to decide, whether abnormal cellular signal transduction is a typical feature and a potential pathogenetic mechanism for DN or just a reflection of the large number of hypertensive individuals who unavoidably accumulate among IDDM patients with DN. On the other hand, an enhanced activation of G i proteins could represent the cellular substrate of a common genetic predisposition for both hypertension and, in the hyperglycaemic condition of IDDM, the development of DN.
Based on our findings, we should like to propose an alternative hypothesis regarding the pathogenesis of nephropathy in IDDM. High extracellular glucose concentration induces an increased de novo synthesis of diacylglycerol (DAG) in the kidney [28] which in turn activates protein kinase C and phospholipase A 2 [29, 30] . This results in the synthesis and release of multiple autocrine and paracrine growth factors as well as lipid mediators involved in the pathogenesis of diabetic nephropathy from early changes to the late stage of irreversible kidney damage.
Glomerular hyperfiltration is the first functional alteration during the early stage of the disease. Alterations in mesangial contractility, which can be caused by the action of PAF and lysophosphatidic acid [31, 32] and an enhanced vasoconstrictor effect of angiotensin II on the vas efferens have been proposed among others [33] . These actions of PAF, lysophosphatidic acid and angiotensin II [34] are largely mediated by PTX-sensitive G proteins in the kidney. Angiotensin II not only stimulates phospholipase C and A 2 , which results in the release of arachidonic acid and an increase in prostaglandin E 2 [35] , but also stimulates extracellular matrix protein synthesis and cellular hypertrophy in glomerular mesangial and proximal tubular cells by the autocrine induction of transforming growth factor b (TGF-b) and plateletderived growth factor (PDGF) [36--38] . PDGF and TGF-b seem to be directly involved in the initiation of cellular hypertrophy, matrix and collagen expression, and glomerulosclerosis. The cellular actions of PDGF are partially mediated by PTX-sensitive G proteins [39, observations from our laboratory].
The above-described mechanisms induced through elevated glucose concentrations are already detrimental in IDDM patients with "normal"" activation of PTX-sensitive G proteins. Patients with enhanced activation of PTX-sensitive G proteins, however, would experience a much more vigorous cellular activation by the above-mentioned compounds. Thus, typical diabetic complications such as DN may develop much earlier and/or be more pronounced during the natural course of IDDM.
In summary, our data apparently support the hypothesis of an inherited predisposition to DN in IDDM patients. This may be due to an increased activation of PTX-sensitive G proteins, which are key mediators in pathogenic processes of this major complication of IDDM. So far, the enhanced activation of G i proteins may serve as an intermediate phenotype for IDDM patients at risk for developing diabetic nephropathy, until a true genetic marker has been identified. 
